Skip to product information
1 of 6

Zoetis

Librela Solution for Injection for Dogs

Librela Solution for Injection for Dogs

Prescription required • Easy online upload or your vet can send it
Commonly claimed back on pet insurance
Regular price £95.99 GBP
Regular price Sale price £95.99 GBP
Sale Sold out
Taxes included.
Strength
Supply
Quantity
Secure checkout – Visa, Mastercard, Apple Pay, Google Pay and PayPal accepted
★★★★★ 5.0 rating from pet owners Read our reviews
Ongoing Treatment Support For ongoing treatments, optional personalised repeat reminders can be set after checkout to help avoid gaps in supply. Please allow time for order processing and delivery.
🚚 Free UK delivery on orders over £75
£3.95 — Royal Mail Tracked 48
£4.95 — Royal Mail Tracked 24

Order before 6pm Monday to Thursday for next working day dispatch once your prescription is approved.

Orders placed Friday to Sunday are usually dispatched on Monday. Selected products may qualify for Saturday dispatch.

Please note We cannot ship to Northern Ireland.

Prescription Information
  • Prescription must match the product, strength and formulation ordered.
  • For orders involving more than one pet, a separate prescription is required.
  • Uploaded prescriptions are valid for up to 6 months or until the prescribed number of repeats has been supplied, whichever comes first. In accordance with UK Veterinary Medicines Regulations, we are legally required to retain veterinary prescriptions for a minimum of 5 years.

All orders are reviewed by our veterinary team. Prescription checks are typically completed the same day. Orders are dispatched once checks are complete and the medication is ready for dispatch. Read our prescription policy.

💡 Some pet insurance policies may cover the cost of prescription medications. Claims and reimbursement depend on your individual policy. Learn more about insurance claims

PRODUCT INFORMATION

Librela Solution for Injection for Dogs

Librela Solution for Injection is a prescription-only veterinary medicine used for the management of osteoarthritis-associated pain in dogs.

Librela contains bedinvetmab, a monoclonal antibody that targets nerve growth factor (NGF), a key mediator involved in osteoarthritic pain.

By targeting this pain signalling pathway, Librela provides targeted pain control for dogs showing clinical signs of osteoarthritis.

This product is a prescription-only veterinary medicine (POM-V) and can only be supplied against a valid veterinary prescription.

What Librela is used for

Librela is used for the management of pain associated with osteoarthritis in dogs.

Osteoarthritis is a progressive degenerative joint disease that commonly affects ageing dogs but may also occur following joint injury or developmental joint disease.

Dogs with osteoarthritis may show signs such as stiffness, reduced activity, difficulty rising, reluctance to jump, or behavioural changes related to chronic pain.

Treatment focuses on controlling pain and improving mobility so affected dogs can maintain a good quality of life.

How Librela works

Librela contains bedinvetmab, a monoclonal antibody that specifically targets nerve growth factor (NGF).

NGF plays a key role in transmitting pain signals associated with osteoarthritis. By binding to NGF, bedinvetmab helps interrupt the pain signalling pathway.

This targeted mechanism helps reduce osteoarthritis-associated pain in dogs.

Administration

Librela is administered as a subcutaneous injection.

Treatment is typically given once monthly, with the dose selected according to the dog’s body weight and clinical response.

Administration is usually carried out by the dog’s primary care veterinary practice.

In some cases, and at the discretion of the prescribing veterinary surgeon, administration may be carried out at home following appropriate instruction.

Monitoring during treatment

Dogs receiving treatment for osteoarthritis should be monitored by a veterinary surgeon to assess response to therapy and overall mobility.

Management of osteoarthritis often includes additional strategies such as weight control, controlled exercise and environmental modifications.

Important information

Librela will be supplied following receipt of a valid veterinary prescription.

Ongoing clinical monitoring by the primary care veterinary practice is recommended as part of long-term osteoarthritis management.

Further information including contraindications, warnings and potential side effects can be found in the product data sheet available here.

Cold chain handling and delivery

This medication must be stored between 2–8°C and protected from freezing immediately on receipt.

All refrigerated medicines are dispatched using validated insulated packaging designed to maintain temperature stability for over 72 hours.

Orders are sent via Royal Mail Signed 24 and an adult must be available to receive the parcel.

If delivery is missed, delayed, redirected or left unattended, temperature integrity cannot be guaranteed. Once dispatched, the cost of refrigerated medicines cannot be refunded.

Cold-chain medicines are dispatched Monday to Thursday to avoid weekend transit delays.

Frequently asked questions

What is Librela used for?

Librela is used to manage pain associated with osteoarthritis in dogs.

How often is Librela given?

Librela is typically administered once monthly as a subcutaneous injection.

How does Librela work?

Librela works by targeting nerve growth factor (NGF), a protein involved in transmitting pain signals associated with osteoarthritis.

Can Librela be given at home?

In some cases, owners may administer Librela at home following instruction from their veterinary practice, although injections are commonly performed by the vet.

Why does Librela require refrigerated delivery?

Librela is a biological medicine that must be stored between 2–8°C to maintain stability and effectiveness.

View full details